Agenus and Zydus Forge Strategic Partnership to Advance BOT/BAL Immunotherapy and Launch BioCDMO Operations in the U.S.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifescienc...

June 05, 2025 | Thursday | News
Lipella Renews Manufacturing Collaboration with Cook MyoSite to Advance Clinical Pipeline

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on devel...

June 05, 2025 | Thursday | News
Forging the Future of Biomanufacturing: How VVMF and Cytiva Are Elevating Australia’s Global Role

As the world recalibrates its life sciences infrastructure post-pandemic, Australia is stepping up as a regional powerhouse in biomanufacturing—espec...

June 05, 2025 | Thursday | Interaction
Trethera Secures Exclusive Worldwide License From UCLA to Expand TRE-515 Patent Protection

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

June 04, 2025 | Wednesday | News
BioAge Labs Expands Obesity Pipeline With APJ Agonist Advances and JiKang Therapeutics Option Deal

BioAge Labs, Inc. ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by t...

June 04, 2025 | Wednesday | News
Merck KGaA, Darmstadt, Germany Ushers in New Era with Appointment of Life Science and Healthcare CEOs

  Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a significant leadership transition with the appointment ...

June 03, 2025 | Tuesday | News
Novartis Reports 33% Reduction in Recurrence Risk for Pre-Menopausal Early Breast Cancer Patients Treated with Kisqali

33% reduction in relative risk of invasive disease observed in pre-menopausal early breast cancer (EBC) patients receiving Kisqali in 1-year post-treat...

June 02, 2025 | Monday | News
Astellas Inks $1.54 Billion Licensing Deal with Evopoint for ADC Candidate XNW27011 Targeting CLDN18.2

- Agreement grants Astellas exclusive worldwide rights (excluding China's mainland, Hong Kong, Macao and Taiwan region) to develop and commercialize XNW2...

May 30, 2025 | Friday | News
Alzamend Doses First Patient in Phase II Trial of AL001, Aiming to Transform Lithium Therapy for Neurological Disorders

Topline data expected by year end Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithi...

May 30, 2025 | Friday | News
Alvotech and Advanz Pharma Expand Biosimilars Partnership with Three New Candidates in Europe

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a U...

May 29, 2025 | Thursday | News
Why CPOs are vital to getting medical trials over the line

While studies to test the safety and efficacy of new drugs are necessary, their success cannot be guaranteed. In fact, it’s likely that at least 80...

May 28, 2025 | Wednesday | News
Sanofi Completes $600M Acquisition of DR-0201, Expanding Immunology Pipeline with First-in-Class Myeloid Cell Engager

 Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private...

May 28, 2025 | Wednesday | News
Altamira Enters Collaboration to Explore CycloPhore™ Delivery of Circular RNA Therapeutics

Exploring use of Altamira’s RNA nanoparticles in conjunction with circular RNA payloads Project collaboration partner will have option to negoti...

May 28, 2025 | Wednesday | News
Liebherr Expands Scientific Line with New Combination Refrigerator-Freezer for Laboratories

Liebherr USA, Co. refrigerators and freezers is excited to announce the addition of a new combination refrigerator-freezer to its scientific appliance li...

May 27, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close